Apical Suspension Repair for Vault Prolapse
The purpose of the “ASPIRe” study is to find out how the results of the surgical procedures compare to each other as well as the advantages and/or disadvantages, risks and benefits, and the effect on quality of life of each surgery when used to repair vaginal vault (apical) prolapse. Physicians can choose from these different types of surgeries to repair vaginal vault (apical) prolapse, but there is not enough information or evidence that demonstrates which surgery provides the best symptom relief and durability while causing the fewest risks.More Information
Biofabrication of Vaginal Support Using Vaginally Derived Cells
The Biofabrication of Vaginal Support Using Vaginally Derived Cells (BioLIFT) feasibility study is looking at whether it is possible to grow ligaments in a laboratory from cells taken from a woman’s vagina during surgery. If this is possible, then the researchers will study whether the ligaments could be used in a vaginal or uterine prolapse repair surgery for that same woman to improve how long the surgical repair lasts.More Information
Extension of the Study of Uterine Prolapse Procedures
The E-SUPeR study extends the follow-up of women in the SUPeR clinical trial up to 10 years from the time of surgery. The primary aim of SUPeR was to determine whether treatment success in women with symptomatic uterovaginal prolapse undergoing transvaginal mesh augmented hysteropexy differs in women undergoing vaginal hysterectomy and native tissue cuff suspension at time points through 3 years. The SUPeR participant population represents a unique opportunity to understand the longer term efficacy and safety outcomes of a native tissue repair and a mesh hysteropexy. Participants will be seen annually for a physical exam and will be asked to complete a reduced set questionnaires (PFDI-20, PFIQ, PGI-I, ISI, and PISQ-IR.)More Information
Mixed Urinary Incontinence: Mid-urethral Sling vs.
The primary objective is to estimate the effect of intradetrusor injections Botulinum toxin A (Botox A ®) compared to mid-urethral sling for treatment of MUI in 146 women 6 months after treatment. The change in severity of MUI symptoms will be measured using the Urogenital Distress Inventory.
Secondary objectives include identifying predictors of treatment failure and cost-effectiveness of treatments in this MUI population.
Proteomics and Pathway Analysis of Women With Mixed Urinary Incontinence-MUSA Supplementary
The primary aim of the PRoMISe study is to characterize baseline putative proteins/protein pathways in women with MUI associated with change in UDI after treatment with MUS or onabotulinum toxin A (i.e., MUSA Trial original subjects, N=110).More Information